BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Reiche W, Tauseef A, Sabri A, Mirza M, Cantu D, Silberstein P, Chandan S. Gastrointestinal manifestations, risk factors, and management in patients with post-transplant lymphoproliferative disorder: A systematic review. World J Transplant 2022; 12(8): 268-280 [PMID: 36159076 DOI: 10.5500/wjt.v12.i8.268]
URL: https://www.wjgnet.com/2220-3230/full/v12/i8/268.htm
Number Citing Articles
1
Agata Marjanska, Jan Styczynski. Who is the patient at risk for EBV reactivation and disease: expert opinion focused on post-transplant lymphoproliferative disorders following hematopoietic stem cell transplantationExpert Opinion on Biological Therapy 2023; 23(6): 539 doi: 10.1080/14712598.2023.2196366
2
Timothy Dean Minniear, Surabhi Vora. How we treat diarrhea in pediatric transplant patients: a brief reviewFrontiers in Pediatrics 2023; 11 doi: 10.3389/fped.2023.1287445
3
Nour Hasan, Ramia Zakhour, Luz Helena Gutierrez Sanchez, Audrey R. Lloyd, Geling Li, Clara L. Ortiz, Cecelia Hutto. Post-Transplant Lymphoproliferative Disorder Presenting as a Gastrointestinal Fistulous Tract in a Heart Transplant Recipient: Case Report and Literature ReviewTransplantation Proceedings 2024;  doi: 10.1016/j.transproceed.2024.07.008